Doximity Inc (NYSE: DOCS)’s stock price has plunge by -0.50relation to previous closing price of 23.88. Nevertheless, the company has seen a -2.30% plunge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-25 that The Zacks Medical – Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and DOCS are set to gain the most.
Is It Worth Investing in Doximity Inc (NYSE: DOCS) Right Now?
The price-to-earnings ratio for Doximity Inc (NYSE: DOCS) is above average at 35.80x. The 36-month beta value for DOCS is also noteworthy at 1.17. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for DOCS is 117.86M, and at present, short sellers hold a 6.82% of that float. The average trading volume of DOCS on May 10, 2024 was 1.56M shares.
DOCS’s Market Performance
The stock of Doximity Inc (DOCS) has seen a -2.30% decrease in the past week, with a -8.09% drop in the past month, and a -15.86% fall in the past quarter. The volatility ratio for the week is 2.61%, and the volatility levels for the past 30 days are at 2.61% for DOCS. The simple moving average for the past 20 days is -3.40% for DOCS’s stock, with a -7.43% simple moving average for the past 200 days.
Analysts’ Opinion of DOCS
Many brokerage firms have already submitted their reports for DOCS stocks, with JP Morgan repeating the rating for DOCS by listing it as a “Neutral.” The predicted price for DOCS in the upcoming period, according to JP Morgan is $25 based on the research report published on April 25, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see DOCS reach a price target of $32. The rating they have provided for DOCS stocks is “Market Perform” according to the report published on February 26th, 2024.
Barclays gave a rating of “Equal Weight” to DOCS, setting the target price at $31 in the report published on January 03rd of the current year.
DOCS Trading at -9.44% from the 50-Day Moving Average
After a stumble in the market that brought DOCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.53% of loss for the given period.
Volatility was left at 2.61%, however, over the last 30 days, the volatility rate increased by 2.61%, as shares sank -10.07% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.96% lower at present.
During the last 5 trading sessions, DOCS fell by -2.30%, which changed the moving average for the period of 200-days by -28.78% in comparison to the 20-day moving average, which settled at $24.46. In addition, Doximity Inc saw -15.26% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DOCS starting from Wampler Kira Scherer, who sale 2,500 shares at the price of $26.97 back on Apr 01 ’24. After this action, Wampler Kira Scherer now owns 10,258 shares of Doximity Inc, valued at $67,425 using the latest closing price.
Wampler Kira Scherer, the Director of Doximity Inc, sale 2,500 shares at $27.88 during a trade that took place back on Mar 01 ’24, which means that Wampler Kira Scherer is holding 10,258 shares at $69,700 based on the most recent closing price.
Stock Fundamentals for DOCS
Current profitability levels for the company are sitting at:
- 0.33 for the present operating margin
- 0.89 for the gross margin
The net margin for Doximity Inc stands at 0.29. The total capital return value is set at 0.17. Equity return is now at value 15.34, with 13.31 for asset returns.
Based on Doximity Inc (DOCS), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at 11.08. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -39.97.
Currently, EBITDA for the company is 135.39 million with net debt to EBITDA at -0.6. When we switch over and look at the enterprise to sales, we see a ratio of 9.23. The receivables turnover for the company is 4.8for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.97.
Conclusion
In summary, Doximity Inc (DOCS) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
